HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eben L Rosenthal Selected Research

Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))

10/2015Dynamic contrast-enhanced MRI evaluates the early response of human head and neck tumor xenografts following anti-EMMPRIN therapy with cisplatin or irradiation.
4/2012(18)F-FDG PET/CT imaging detects therapy efficacy of anti-EMMPRIN antibody and gemcitabine in orthotopic pancreatic tumor xenografts.
10/2011Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapy.
8/2011Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells.
10/2010Anti-EMMPRIN antibody treatment of head and neck squamous cell carcinoma in an ex-vivo model.
6/2009Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer.
2/2009EMMPRIN expression is required for response to bevacizumab therapy in HNSCC xenografts.
11/2008Modulation of tumor cell growth in vivo by extracellular matrix metalloprotease inducer.
7/2006Extracellular matrix metalloprotease inducer stimulates fibroblast-mediated tumor growth in vivo.
4/2005Extracellular matrix metalloprotease inducer-expressing head and neck squamous cell carcinoma cells promote fibroblast-mediated type I collagen degradation in vitro.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eben L Rosenthal Research Topics

Disease

98Neoplasms (Cancer)
11/2022 - 08/2003
37Squamous Cell Carcinoma of Head and Neck
10/2021 - 08/2003
30Head and Neck Neoplasms (Head and Neck Cancer)
10/2021 - 03/2002
13Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2019 - 02/2010
11Fistula
01/2017 - 05/2007
7Neoplasm Metastasis (Metastasis)
10/2021 - 07/2006
6Wounds and Injuries (Trauma)
01/2015 - 11/2005
5Glioma (Gliomas)
11/2021 - 02/2014
5Carcinoma (Carcinomatosis)
01/2018 - 08/2004
5Infections
11/2013 - 07/2008
4Lymphatic Metastasis
10/2021 - 04/2014
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 10/2011
4Hypothyroidism
01/2017 - 08/2012
4Breast Neoplasms (Breast Cancer)
11/2014 - 01/2004
3Osteonecrosis (Kienbock's Disease)
11/2021 - 08/2012
3Residual Neoplasm
12/2016 - 10/2011
3Hemorrhage
01/2015 - 07/2008
3Oropharyngeal Neoplasms
01/2015 - 02/2010
3Osteoradionecrosis
08/2012 - 05/2009
3Laryngeal Neoplasms (Laryngeal Cancer)
04/2012 - 08/2003
3Deglutition Disorders (Dysphagia)
11/2011 - 06/2006
2Margins of Excision
11/2022 - 11/2007
2Necrosis
01/2022 - 04/2012
2Melanoma (Melanoma, Malignant)
12/2016 - 11/2013
2Hematoma
06/2014 - 07/2013
2Diabetes Mellitus
03/2014 - 02/2014
2Pathologic Constriction (Stenosis)
03/2012 - 05/2007
1Glioblastoma (Glioblastoma Multiforme)
11/2020

Drug/Important Bio-Agent (IBA)

17ErbB Receptors (EGF Receptor)IBA
11/2022 - 04/2007
13Cetuximab (Erbitux)FDA Link
10/2020 - 04/2007
11Panitumumab (Vectibix)FDA Link
10/2021 - 11/2012
11AntibodiesIBA
10/2020 - 07/2012
11Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
10/2015 - 08/2003
11Metalloproteases (Metalloproteinases)IBA
10/2015 - 08/2003
10Monoclonal AntibodiesIBA
12/2016 - 06/2009
8Proteins (Proteins, Gene)FDA Link
11/2021 - 08/2003
8Coloring Agents (Dyes)IBA
10/2021 - 01/2017
7Fluorescent Dyes (Fluorescent Probes)IBA
01/2022 - 04/2007
7Immunoglobulin G (IgG)IBA
10/2020 - 04/2007
6Biomarkers (Surrogate Marker)IBA
11/2022 - 02/2009
6Matrix Metalloproteinases (MMPs)IBA
01/2020 - 08/2004
5Contrast MediaIBA
11/2019 - 04/2007
4Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2022 - 11/2007
4ParaffinIBA
10/2020 - 06/2013
4Bevacizumab (Avastin)FDA Link
12/2016 - 02/2009
4Cisplatin (Platino)FDA LinkGeneric
10/2015 - 08/2007
4EnzymesIBA
11/2011 - 04/2005
3LigandsIBA
11/2022 - 08/2011
3Growth Factor ReceptorsIBA
10/2021 - 11/2007
3Pharmaceutical PreparationsIBA
01/2020 - 10/2013
3LuciferasesIBA
06/2018 - 11/2014
3Small Interfering RNA (siRNA)IBA
06/2009 - 11/2008
3CY5.5 cyanine dyeIBA
07/2008 - 04/2007
3Matrix Metalloproteinase 14 (MT1-MMP)IBA
07/2006 - 08/2004
2Biological FactorsIBA
11/2022 - 01/2020
2Indicators and Reagents (Reagents)IBA
10/2021 - 01/2011
2Immunoconjugates (Immunoconjugate)IBA
11/2020 - 11/2020
2Peptides (Polypeptides)IBA
01/2020 - 08/2012
2DNA (Deoxyribonucleic Acid)IBA
01/2017 - 09/2015
2AntigensIBA
01/2017 - 09/2014
2Fibroblast Growth Factor 1 (FGF-1)IBA
01/2016 - 08/2011
2Therapeutic UsesIBA
10/2015 - 09/2014
2antineoplaston A10 (A 10)IBA
09/2015 - 01/2014
2IRDye800IBA
08/2015 - 03/2013
2Messenger RNA (mRNA)IBA
01/2015 - 08/2004
2Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2014 - 04/2013
2DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
07/2012 - 11/2008
2Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
07/2012 - 08/2011
2PD 173074IBA
07/2012 - 08/2011
2Collagen Type I (Type I Collagen)IBA
03/2006 - 04/2005
2Peptide Hydrolases (Proteases)FDA Link
04/2005 - 08/2004
1Molecular Probes (Molecular Probe)IBA
11/2022
1IntegrinsIBA
01/2022
1Biological ProductsIBA
01/2022
1mesoglycanIBA
01/2022
1Interleukin-15 (Interleukin 15)IBA
01/2021
1Formaldehyde (Formol)FDA Link
01/2021
1Hematoxylin (Haematoxylon)IBA
10/2019

Therapy/Procedure

38Therapeutics
01/2021 - 06/2006
17Free Tissue Flaps
11/2021 - 03/2002
15Radiotherapy
01/2018 - 05/2008
8Laryngectomy
01/2017 - 05/2007
7Neck Dissection (Radical Neck Dissection)
11/2019 - 01/2010
7Gastrostomy
01/2016 - 04/2009
6Computer-Assisted Surgery (Image Guided Surgery)
01/2022 - 08/2015
5Drug Therapy (Chemotherapy)
10/2015 - 01/2009
5Length of Stay
01/2015 - 05/2007
4Tracheostomy
01/2016 - 05/2009
4Negative-Pressure Wound Therapy
03/2014 - 11/2005
4Robotic Surgical Procedures
07/2013 - 04/2009
4Aftercare (After-Treatment)
12/2011 - 06/2006
3Lasers (Laser)
01/2017 - 08/2004
2Chemoradiotherapy
01/2017 - 02/2010
2Photochemotherapy (Photodynamic Therapy)
01/2016 - 11/2014
2Glossectomy
01/2015 - 11/2011
2Injections
01/2014 - 12/2013
2Mandibular Osteotomy
11/2013 - 11/2003
2Enteral Nutrition (Feeding, Tube)
08/2009 - 05/2007
2Conservative Treatment
07/2008 - 06/2006
1Precision Medicine
11/2020